Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Typical antipsychotic
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Clinical uses == Typical antipsychotics block the [[Dopamine receptor D2|dopamine 2 receptor (D2)]] receptor, causing a tranquilizing effect.<ref name="Schatzberg 2019">{{cite book |title=Schatzberg's Manual of Clinical Psychopharmacology |date=2019 |publisher=American Psychiatric Association Publishing |isbn=978-1-61537-230-0 |edition=Ninth |url=https://www.appi.org/Products/Psychopharmacology/Schatzbergs-Manual-of-Clinical-Psychopharmacology |access-date=2020-06-21 |archive-date=2020-06-21 |archive-url=https://web.archive.org/web/20200621155952/https://www.appi.org/Products/Psychopharmacology/Schatzbergs-Manual-of-Clinical-Psychopharmacology |url-status=dead }}</ref> It is thought that 60β80% of D2 receptors need to be occupied for antipsychotic effect.<ref name="Schatzberg 2019" /> For reference, the typical antipsychotic [[haloperidol]] tends to block about 80% of D2 receptors at doses ranging from 2 to 5 mg per day.<ref name="Schatzberg 2019" /> On the aggregate level, no typical antipsychotic is more effective than any other, though people will vary in which antipsychotic they prefer to take based on individual differences in tolerability and effectiveness.<ref name="Schatzberg 2019" /> Typical antipsychotics can be used to treat, e.g., schizophrenia or severe agitation.<ref name="Schatzberg 2019" /> Haloperidol, due to the availability of a rapid-acting injectable formulation and decades of use, remains the most commonly used antipsychotic for treating severe agitation in the emergency department setting.<ref name="Schatzberg 2019" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)